Search

Author/Creator Rigg, Anne

1. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019)

Authors:
Earl, Helena M; Hiller, Louise; Vallier, Anne-Laure; Loi, Shrushma; McAdam, Karen; Hughes-Davies, Luke; Harnett, Adrian N; Ah-See, Mei-Lin; Simcock, Richard; Rea, Daniel; Raj, Sanjay; Woodings, Pamela; Harries, Mark; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Ma...
Journal:
Lancet
Issue:
Volume 393:Issue 10191(2019)
Page Start:
2599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England. (March 2022)

Authors:
Fox, Louis; Monroy-Iglesias, Maria J.; Aggarwal, Ajay; Haire, Kate; Purushotham, Arnie; Spicer, James; Papa, Sophie; Rigg, Anne; Dolly, Saoirse; Sullivan, Richard; Van Hemelrijck, Mieke
Journal:
Journal of cancer policy
Issue:
Volume 31(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Issue 6 (June 2021)

Authors:
Monin, Leticia; Laing, Adam G; Muñoz-Ruiz, Miguel; McKenzie, Duncan R; del Molino del Barrio, Irene; Alaguthurai, Thanussuyah; Domingo-Vila, Clara; Hayday, Thomas S; Graham, Carl; Seow, Jeffrey; Abdul-Jawad, Sultan; Kamdar, Shraddha; Harvey-Jones, Elizabeth; Graham, Rosalind; Cooper, Jack; Khan, ...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 6(2021)
Page Start:
765
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗